FDA/CMS Discussing Liaison Office To Improve Coverage Decisions
Executive Summary
FDA is considering the creation of a liaison office to provide guidance to the Centers for Medicare & Medicaid Services on federal coverage decisions for new products
You may also be interested in...
Generic Biologics Are Coming, Commissioner McClellan Tells MBC
Biogen is understood to be drafting a position statement on generic biologics on behalf of the Massachusetts Biotechnology Council
Generic Biologics Are Coming, Commissioner McClellan Tells MBC
Biogen is understood to be drafting a position statement on generic biologics on behalf of the Massachusetts Biotechnology Council
FDA, CMS Coordination On Coverage Decisions May Improve Under McClellan
FDA and the Centers for Medicare & Medicaid Services are likely to have a closer relationship under incoming Commissioner McClellan